Long term outcome after combined modality treatment for anal cancer

Radiology and Oncology

Volumn 46, Issue 2, 2012, Pages 145-152

  Oblak, Irena ^a   Petric, Primoz ^a   Anderluh, Franc ^a   Velenik, Vaneja ^a   Fras, Peter Albert ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

anal cancer; outcome; radiochemotherapy; salvage surgery

Indexed keywords

FLUOROURACIL; HEMOGLOBIN; MITOMYCIN C;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; OUTCOME ASSESSMENT; RADIATION DERMATITIS; RADIATION INJURY; RETROSPECTIVE STUDY; SALVAGE THERAPY; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; STOMATITIS; SURGICAL INFECTION; THROMBOCYTE COUNT; VOMITING;

EID: 84861913298     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-012-0022-2     Document Type: Article

References (35)

1. Rousseau DL, Thomas CR, Petrelli NJ, Kahlenberg MS. Sqamous cell carcinoma of the anal canal. Surg Oncol 2005; 14: 121-32. (Pubitemid 41676782)
2. But-Hadzic J, Jenko K, Poljak M, Kocjan BJ, Gale N, Strojan P. Sinonasal inverted papilloma associated with squamous cell carcinoma. Radiol Oncol 2011; 45: 267-72.
3. Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P. Prognostic value of tumour regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1316-24. (Pubitemid 41628024)
4. Cancer incidence in Slovenia 2003. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2006.
5. Cancer incidence in Slovenia 2004. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2007.
6. Cancer incidence in Slovenia 2005. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2008.
7. Cancer incidence in Slovenia 2006. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
8. Cancer incidence in Slovenia 2007. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2010.
9. Nigro ND, Vaitkevicius VK, Considine D. Combined therapy for cancer of the anal canal. Dis Colon Rectum 1974; 27: 763-6.
10. Fraunholz I, Rebeneck D, Weiß C, Rödel C. Combined-modality treatment for anal cancer. Strahlenther Oncol 2010; 186: 361-6.
11. Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, et al. Radiochemotherapy in the conservative treatment of anal canal carcinoma: Retrospective analysis of the results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 2005; 61: 1136-42. (Pubitemid 40340908)
12. Oblak I, Petric P, Anderluh F, Velenik V, Hudej R, Fras AP. Anal cancer chemoirradiation with curative intent - a single institution experience. Neoplasma 2009; 56: 150-5.
13. Sobin LH, Gospodarowitcz MK, Wittekind C. International Union Against Cancer (UICC): TNM classification of malignant tumours. 7th edition. New York: Wiley-Liss; 2009.
14. Strojan P. Role of radiotherapy in melanoma management. Radiol Oncol 2010; 44: 1-12.
15. Ajani JA, Welch SR, Raber MN, Fiels WS, Krakoff IM. Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 1990; 8: 147-59. (Pubitemid 20350387)
16. LENT-SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995; 31: 1049-91.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
18. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39. (Pubitemid 8018922)
19. Cox DR. Regression models and life-tables. J R Stat Soc Bull 1972; 34: 187-220.
20. Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM, et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 1998; 46: 249-56. (Pubitemid 28157274)
21. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of mitomycin in combination with florouracil and radiotherapy, and a salvage chemoradiotherapy in the definitive nonsurgical treatment of the epidermoid carcinoma of the anal canal: results of a phase III randomozed intergroup study. J Clin Oncol 1996; 14: 2527-39. (Pubitemid 26300120)
22. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008; 299: 1914-21. (Pubitemid 351574921)
23. Peiffert D, Bey P, Pernot M, Guillemin F, Luporsi E, Hoffstetter S, et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal. Prognostic factors of tumoural control and complications. Int J Radiat Oncol Biol Phys 1997; 37: 313-24. (Pubitemid 27138714)
24. Akbari RP, Paty PB, Guillem JG, Weiser MR, Temple LK, Minsky BD, et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 2004; 47: 1136-44. (Pubitemid 38857060)
25. Cummings BJ, Brierley JD. Anal Cancer. In: Halperin EC, Perez CA, Brady LW, editors. Principles and Practice of Radiation Oncology. 5th edition. Philadelphia: Lippincott Williams& Wilkins, 2008. p. 1383-96.
26. Schiller DE, Cummings BJ, Rai S, Le LW, Last L, Davey P, et al. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol 2007; 14: 2780-9. (Pubitemid 47460652)
27. Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 1998; 41: 1488-93. (Pubitemid 28565459)
28. Oblak I, Strojan P, Zakotnik B, Budihna M, Smid L. Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy. Neoplasma 2003; 50: 452-8. (Pubitemid 38009588)
29. Horsman MR, Van der Kogel A. Therapeutic approaches to tumour hypoxia. In: Joiner M, Van der Kogel A, editors. Basic Clinical Radiobiology. 4th edition. London: Hodder Arnold, 2009. p. 233-45.
30. Sato H, Koh PK, Bartolo DCC. Management of anal canal cancer. Dis Colon Rectum 2005; 48: 1301-15. (Pubitemid 40897880)
31. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991; 21: 1115-25.
32. Marshall DT, Thomas CR. Carcinoma of the anal canal. Oncol Rev 2009; 3: 27-40.
33. Mitchell SE, Mendenhal WM, Zlotecki RA, Carroll RR. Squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2001; 45: 1007-13. (Pubitemid 32184606)
34. Hwang JM, Rao AR, Cosmatos HA, Wang R, Kaptein JS, Kagan RA, et al. Treatment of T3 and T4 anal carcinoma with combined chemotharapy and interstitial 192-Ir implantation: a 10-year experience. Brachytherapy 2004; 3: 95-100. (Pubitemid 39221353)
35. Bailey DW, Kumaraswamy L, Podgorsak MB. A fully electronic intensity-modulated radiation therapy quality assurance (IMRT QA) process implemented in a network comprised of independent treatment planning, record and verify, and delivery systems. Radiol Oncol 2010; 44: 124-30.